Amphastar Pharmaceuticals (AMPH) Leases (2016 - 2025)
Amphastar Pharmaceuticals (AMPH) has 13 years of Leases data on record, last reported at $259000.0 in Q3 2025.
- For Q3 2025, Leases fell 39.2% year-over-year to $259000.0; the TTM value through Sep 2025 reached $259000.0, down 39.2%, while the annual FY2024 figure was $383000.0, 32.09% down from the prior year.
- Leases reached $259000.0 in Q3 2025 per AMPH's latest filing, down from $296000.0 in the prior quarter.
- Across five years, Leases topped out at $32.7 million in Q3 2023 and bottomed at $201000.0 in Q2 2022.
- Average Leases over 5 years is $8.9 million, with a median of $564000.0 recorded in 2023.
- Peak YoY movement for Leases: tumbled 99.26% in 2022, then soared 9180.94% in 2023.
- A 5-year view of Leases shows it stood at $26.9 million in 2021, then plummeted by 97.2% to $753000.0 in 2022, then fell by 25.1% to $564000.0 in 2023, then tumbled by 32.09% to $383000.0 in 2024, then tumbled by 32.38% to $259000.0 in 2025.
- Per Business Quant database, its latest 3 readings for Leases were $259000.0 in Q3 2025, $296000.0 in Q2 2025, and $335000.0 in Q1 2025.